IDEXX Laboratories
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. IDEXX Laboratories's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9% to $3,660,953,000. The net income raised on $845,042,000 and profit margin reached 23%. Total operating expenses were $1,092,842,000.
Profit Margin
| 2014 | 1.48B | 181.90M | 12.24% |
|---|---|---|---|
| 2015 | 1.60B | 192.07M | 11.99% |
| 2016 | 1.77B | 222.04M | 12.51% |
| 2017 | 1.96B | 263.14M | 13.36% |
| 2018 | 2.21B | 377.03M | 17.04% |
| 2019 | 2.40B | 427.72M | 17.77% |
| 2020 | 2.70B | 581.77M | 21.49% |
| 2021 | 3.21B | 744.84M | 23.17% |
| 2022 | 3.36B | 679.08M | 20.17% |
| 2023 | 3.66B | 845.04M | 23.08% |
IDXX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 3.66B | 3.36B | 3.21B | 2.70B | 2.40B | 2.21B | 1.96B | 1.77B | 1.60B | 1.48B |
Cost of revenue | 1.47B | 1.36B | 1.32B | 1.13B | 1.04B | 971.7M | 871.67M | 799.98M | 711.62M | 669.69M |
Gross profit | 2.18B | 2.00B | 1.88B | 1.57B | 1.36B | 1.24B | 1.09B | 975.43M | 890.27M | 816.11M |
Operating exp. | ||||||||||
Research and development | 190.95M | 254.82M | 161.00M | 141.24M | 133.19M | 117.86M | 109.18M | 101.12M | 99.68M | 98.26M |
Selling and marketing | 566.06M | 524.50M | 486.73M | 434.43M | 418.19M | 387.40M | 354.29M | 317.05M | 299.95M | 283.70M |
Total operating expenses | 1.09B | 1.10B | 957.40M | 876.51M | 812.70M | 750.20M | 684.35M | 625.19M | 582.14M | 555.86M |
Operating income | 1.09B | 898.76M | 932.02M | 694.52M | 552.84M | 491.33M | 413.02M | 350.23M | 299.91M | 260.25M |
Other income (expenses), net | -35.95M | -38.79M | -29.37M | -32.53M | -30.62M | -33.59M | -31.97M | -28.39M | -26.77M | -13.7M |
Income before tax | 1.06B | 859.97M | 902.65M | 661.98M | 522.21M | 457.74M | 381.05M | 321.84M | 273.14M | 246.55M |
Income tax expense | 216.13M | 180.88M | 157.81M | 79.85M | 94.42M | 80.69M | 117.78M | 99.79M | 81.00M | 64.60M |
Net income | 845.04M | 679.08M | 744.84M | 581.77M | 427.72M | 377.03M | 263.14M | 222.04M | 192.07M | 181.90M |
Earnings per share | ||||||||||
Basic EPS | 10.17 | 8.12 | 8.74 | 6.82 | 4.97 | 4.34 | 3 | 2.47 | 2.07 | 1.82 |
Diluted EPS | 10.06 | 8.03 | 8.6 | 6.71 | 4.89 | 4.26 | 2.94 | 2.44 | 2.05 | 1.79 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |